All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

Compass Pathways said on Tuesday its psilocybin-based therapy eased depression symptoms in a late-stage trial, sending the ...

Today, Compass updated investors on its drug trial progress, and the stock shot higher. Compass announced two Phase 3 trials ...

Aires operates under an independent, performance-based model, partnering only with providers who meet or surpass expectations ...

A Warning From Inside the Washington Post’s Unraveling MIAMI, FL, UNITED STATES, February 5, 2026 /EINPresswire.com/ -- ...

New research benchmarks 12 solution providers and reveals why AI interviewers are spreading faster than governance can ...

New subscription platform brings validated nonprofit data into one workspace to save time; expands discovery beyond ...

Compass Point is pleased to announce the expansion of its Real Estate Research Team with the addition of Mr. Robert ...

Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase 3 trial in depression.

Eight-week program supports nonprofits, especially small teams, to show up where donors and funders search SEATTLE, WA, ...

Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical ...

The Jeep Compass still holds its spot as the entry point to the automaker’s SUV range, with compact size, standard all-wheel ...